Using fragment-based drug discovery to identify small molecule inhibitors of SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase (RdRp) and future starting points for other Coronaviruses

  • Scanlon, Martin (Chief Investigator (CI))
  • Angell, Richard (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

TIA accelerator voucher scheme - Covid projects
StatusActive
Effective start/end date20/10/2019/10/21